The global Extracellular Matrix Market Growth Accelerated by Rise in Orthopedic and Wound Healing Applications
The global Extracellular Matrix Market is estimated to be valued at US$ 46.12 Bn in 2023 and is expected to exhibit a CAGR of 9.8% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Extracellular matrix (ECM) is found throughout the human body. It provides structural support to surrounding cells and plays an important role in coordinating cellular behavior. ECM products available in the market mimic the body's own ECM and support tissue regeneration and wound healing. ECM is used in various orthopedic, general surgery, gynecology, and urology applications.
Market key trends:
The key trend accelerating the growth of the extracellular
matrix market size is the increasing applications of ECM in the field
of orthopedics and wound healing. Extracellular matrices are finding widespread
use in various orthopedic procedures such as hernia repair, rotator cuff
repair, cartilage repair, and breast reconstruction. Studies have shown that
ECM derived scaffolds stimulate wound healing by enhancing
re-epithelialization, granulation tissue formation, angiogenesis, and
decreasing inflammation. They also act as a template by promoting the
migration, proliferation, and differentiation of cells involved in wound
healing. Rising demand for advanced wound care options and favorable
reimbursement policies for ECM products are boosting their adoption in wound
management applications.
Segment Analysis
The global extracellular matrix market can be segmented based on application,
product type, composition, material, and end user. By application, the
reconstructive segment dominated the market in 2023 due to the increasing
prevalence of wounds globally. Sub-segment reconstructive includes soft tissue
repair, hernia repair, breast reconstruction, and dural repair.
Key Takeaways
The global extracellular matrix market is expected to witness high growth
during the forecast period of 2023-2030.
Regional Analysis
North America dominated the global extracellular matrix market in 2023 due
to the rising prevalence of chronic diseases and rapid technological
advancements in the region. Moreover, the presence of key players and robust
research activities fuel market growth in North America.
Key players
Key players operating in the extracellular matrix market are Thermo Fisher
Scientific, DSM, Acelity (KCI Concepts), Corning Incorporated, Baxter, FUJIFILM
Holdings Corporation, Integra LifeSciences, CellSystems Biotechnologie Vertrieb
GmbH, Biotime, Inc., Trevigen, Inc., Advanced BioMatrix, Collagen Matrix, Inc.,
Merck KGaA, VWR International LLC, REPROCELL USA Inc., BioLamina AB, Matricel
GmbH, Tissue Regenix, Admedus, MIMETAS.
Get
more insights on this topic: https://www.newsstatix.com/extracellular-matrix-market-share-and-opportunity-analysis-2023-2030/
Comments
Post a Comment